| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | ACETAMINOPHEN | 3 |
| 2 | ASPIRIN | 3 |
| 3 | ASPIRIN 325 MG | 3 |
| 4 | ASPIRIN 81 MG | 3 |
| 5 | GABAPENTIN | 3 |
| 6 | METHOTREXATE SODIUM | 3 |
| 7 | ONABOTULINUMTOXINA | 3 |
| 8 | VALSARTAN | 3 |
| 9 | VALSARTAN ORAL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUGAMMADEX SODIUM | 1 | 0.0008 |
| 1 | PSYLLIUM HUSK | 1 | 0.0007 |
| 2 | MITOMYCIN | 2 | 0.0005 |
| 3 | SUGAMMADEX | 1 | 0.0004 |
| 4 | NUSINERSEN | 2 | 0.0003 |
| 5 | ATOGEPANT | 1 | 0.0001 |
| 6 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 1 | 0.0001 |
| 7 | CAPTOPRIL | 1 | 0.0001 |
| 8 | CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | 1 | 0.0001 |
| 9 | CLOBETASOL PROPIONATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antisense Oligonucleotide [EPC] | 2 | 0.0002 |
| 1 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 3 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 5 | Central alpha-2 Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 6 | Androgen [EPC] | 1 | 0.0000 |
| 7 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Acetylcholine Release Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Androgen Receptor Inhibitor [EPC] | 2 | 0.0000 |